R. Michael Gendreau appointed Chief Medical Officer by Intec Pharma

Clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion Pill  platform technology, Intec Pharma appointed R. Michael Gendreau, MD., Ph.D to the position of Chief Medical Officer. R. Michael Gendreau ushers in 30 years of experience in drug development and pharmaceutical industry.

Jeffrey A. Meckler, Chief Executive Officer of Intec Pharma said “I am delighted to have Michael join our executive team. He is an extraordinarily talented individual who has extensive clinical trial experience and has helped obtain multiple FDA approvals.”

Dr. Gendreau has founded a consulting firm providing strategic advice in the design and management of clinical programs strategic planning, and technology assessments for emerging pharmaceutical, diagnostic, and medical device companies. He has served on various scientific advisory boards, executive strategic planning boards, and Data Safety Monitoring Boards. Prior to his consulting career, Dr. Gendreau served as Chief Medical Officer at Cypress Bioscience.